Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04617002
Title Intermediate-size Expanded Access to ONC201 for Patients With H3 K27M-mutant and/or Midline Gliomas
Recruitment Available
Gender both
Phase Expanded access
Variant Requirements No
Sponsors Oncoceutics, Inc.
Indications

central nervous system cancer

brain stem glioma

Therapies

ONC201

Age Groups: adult | child | senior
Covered Countries USA


No variant requirements are available.